Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events

Featured Stories

Hot information:
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jun 07,2018
Artificial Human Prions Created in the Lab
Brain-wasting disorders often evoke a sense of fear and panic from both researchers and the general public alike. For scientists, this sense of dread stems from gaps in the knowledge base of the full pathogenesis for these diseases and a deficiency in effective treatments. What is understood, however, is the cause of wasting disorders likeRead more
More
Artificial Human Prions Created in the Lab
Jun 07,2018
Dog Germs Diversify, May Threaten Humans with Flu Pandemics
If you lie with dogs, you might get fleas – or worse, an influenza virus that is completely unfamiliar to your immune defenses. The risk appears to be rising, says an international team of scientists that has been studying how influenza viruses jump from species to species. In a new study, these scientists present evidenceRead more
More
Jun 06,2018
Artificial Bone Marrow Supports Blood Stem Cells for Disease Modelling and Drug Discovery
Bone marrow tissue functions like a conveyor belt for our bloodstream, pumping out billions of blood cells each day to keep our bodies in healthy, working order. Scientists have now made a promising advance in the effort to recreate this effect with an artificial version, a tool that could be weaponized in the fight againstRead more
More
Jun 06,2018
Speeding Drug Development with Clinical Trials in a Dish
The average time to bring a new drug to market is 12 years – assuming it makes it through the rigorous regulatory hurdles. Any technology or methodology that can expedite the drug development process or increase the likelihood of FDA approval is advantageous to both companies and patients. Now, a new study from investigators atRead more
More
Speeding Drug Development with Clinical Trials in a Dish
Jun 05,2018
Green Tea Molecule Could Prevent Heart Attacks
Time and time again we've seen research backing the health benefits of green tea. The powerful supplement can help to lose weight, boost memory, and lower psychological stress. Now researchers believe a potent substance found in green tea can reduce the risk of heart attacks.   A natural polyphenol found in green tea could holdRead more
More
Jun 05,2018
New "Egg Tumor Model” Developed to Study Cancer
Researchers say they have developed a versatile, powerful, and convenient model to analyze human cancer. They put together an "egg tumor model” in which cultured ovarian cancer cells are transplanted on top of the membrane that surrounds a 10-day-old chicken embryo. An ovarian tumor forms on top of the membrane within three days of transplantation. TheRead more
More
New "Egg Tumor Model” Developed to Study Cancer
Jun 04,2018
Parkinson's Risk Decreased among Immunosuppressant Users
Drugs that suppress a patient's immune system are a necessity when battling a variety of diseases and after life-saving organ transplant procedures. Unfortunately, these essential drugs also come with an array of unwelcome potential side effects – namely increasing the patient's susceptibility to normally well-tolerated infections, which then become life-threatening.
More
Parkinson's Risk Decreased among Immunosuppressant Users
Jun 04,2018
Humans’ Big Brains May Be Partly Due to Three Newly Found Genes
The brains of humans are conspicuously larger than the brains of other apes, but the human-specific genetic factors responsible for the uniquely large human neocortex remain obscure. Since humans split from chimps, which have brains roughly a third of human size, the human genome has undergone roughly 15 million changes. Which of these genetic tweaksRead more
More
Jun 01,2018
Alzheimer's Gets Boost from Plasmalogen Study to Help Understand Molecular Processes
Alzheimer's disease patients lose up to 60% of a component called plasmalogen from the membranes of the cells in their brains, but it's still not known how or why. In a paper ("Cytochrome c Is an Oxidative Stress-Activated Plasmalogenase That Cleaves Plasmenylcholine and Plasmenylethanolamine at the sn-1 Vinyl–Ether Linkage”) to be published in the Journal ofRead more
More
Alzheimer's Gets Boost from Plasmalogen Study to Help Understand Molecular Processes
Jun 01,2018
Antimicrobial Triclosan Changes Microbiota, Linked with Colitis and Colon Cancer
The chemical triclosan is used as an antimicrobial agent in more than 2000 consumer products, from toothpaste and cosmetics to kitchenware and toys. Studies in mice by a team of scientists in the U.S. and China have now linked short-term dietary exposure to triclosan with altered gut microbiota, colonic inflammation, worsening colitis, and colitis-associated colonRead more
More
Antimicrobial Triclosan Changes Microbiota, Linked with Colitis and Colon Cancer